Beth Taylor Sells 4,370 Shares of Inotiv, Inc. (NASDAQ:NOTV) Stock

Inotiv, Inc. (NASDAQ:NOTV) CFO Beth Taylor sold 4,370 shares of the stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $4.01, for a total value of $17,523.70. Following the completion of the sale, the chief financial officer now owns 108,368 shares of the company’s stock, valued at approximately $434,555.68. This represents a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Beth Taylor also recently made the following trade(s):

• On Friday, January 31st, Beth Taylor sold 2,054 shares of Inotiv stock. The stock was sold at an average price of $4.46, for a total transaction of $9,160.84.

Inotiv Stock Performance

Shares of NOTV stock opened at $4.06 on Friday. The company’s fifty day moving average price is $4.33 and its two-hundred day moving average price is $2.95. The company has a debt-to-equity ratio of 2.31, a current ratio of 1.57 and a quick ratio of 1.28. The firm has a market capitalization of $136.90 million, a P/E ratio of -0.88 and a beta of 3.58. Inotiv, Inc. has a 12 month low of $1.23 and a 12 month high of $11.42.

Inotiv (NASDAQ:NOTV) last issued its quarterly earnings results on Wednesday, February 5th. The company reported ($0.42) EPS for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.10). Inotiv had a negative net margin of 25.40% and a negative return on equity of 15.41%. On average, research analysts anticipate that Inotiv, Inc. will post -0.79 earnings per share for the current fiscal year.

Institutional Trading of Inotiv

Institutional investors have recently added to or reduced their stakes in the stock. Two Sigma Advisers LP increased its position in shares of Inotiv by 31.6% in the 4th quarter. Two Sigma Advisers LP now owns 22,500 shares of the company’s stock worth $93,000 after purchasing an additional 5,400 shares during the last quarter. Two Sigma Investments LP increased its holdings in Inotiv by 67.8% in the fourth quarter. Two Sigma Investments LP now owns 71,689 shares of the company’s stock valued at $297,000 after buying an additional 28,965 shares during the last quarter. Mink Brook Asset Management LLC acquired a new stake in Inotiv during the fourth quarter valued at approximately $223,000. Millennium Management LLC lifted its holdings in Inotiv by 553.7% during the 4th quarter. Millennium Management LLC now owns 287,899 shares of the company’s stock worth $1,192,000 after buying an additional 243,860 shares during the last quarter. Finally, Cubist Systematic Strategies LLC grew its position in shares of Inotiv by 500.0% in the 4th quarter. Cubist Systematic Strategies LLC now owns 83,923 shares of the company’s stock worth $347,000 after acquiring an additional 69,936 shares in the last quarter. 18.17% of the stock is owned by institutional investors and hedge funds.

About Inotiv

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.